Potential association between erythromycin and cholestatic hepatitis

Med Intensiva. 2016 Jun-Jul;40(5):319-20. doi: 10.1016/j.medin.2015.10.001. Epub 2015 Dec 18.

[Article in English, Spanish]

Authors

M Mondragón-Navarro¹, J M Raurich², J I Ayestarán², A Colomar², M Ferreruela²

Affiliations

¹ Servei de Medicina Intensiva, Hospital Universitari Son Espases, Palma de Mallorca, España. Electronic address: [email protected].
² Servei de Medicina Intensiva, Hospital Universitari Son Espases, Palma de Mallorca, España.

PMID: 26707838
DOI: 10.1016/j.medin.2015.10.001

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Anti-Bacterial Agents / adverse effects*
Anti-Bacterial Agents / therapeutic use
Cholestasis, Intrahepatic / chemically induced*
Critical Care
Erythromycin / adverse effects*
Erythromycin / therapeutic use
Humans
Male
Respiration, Artificial
Retropharyngeal Abscess / drug therapy
Retropharyngeal Abscess / etiology
Shock, Septic / etiology
Streptococcal Infections / complications
Streptococcal Infections / drug therapy
Streptococcus anginosus
Tonsillitis / drug therapy

Substances

Anti-Bacterial Agents
Erythromycin